SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1718)2/9/1999 11:21:00 AM
From: John Bloxom  Respond to of 10280
 
Peter:

Thanks for that information (of which I was unaware). I am faxing it up to New York now for analysis and will advise further soon.

Thanks again,

John



To: Biomaven who wrote (1718)2/9/1999 4:35:00 PM
From: sim1  Read Replies (2) | Respond to of 10280
 
Peter, do you have an opinion on which company (CRO or CELG or both)
might be a better play on the single isomer Ritalin? Looks like CRO
trades on the London Stock Exchange for about $4. Thanks for your
thoughts.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News